Page 10 - ANWITA DEVELOPMENT TO TT
P. 10

FULL PROCESS OVERVIEW




                                                                          QP declaration

                                                                          Medical writing
                                                   Scientific advice  RA Submission Strategy                           Distribution Licensing


                             Formulation        Preclinical and clinical  Marketing Authorization                      Batch Release Batch
                             Development              strategy             Application                                       Testing



                               Product        Preclinical      Clinical                      Regulatory     Post approval    Commer-
          Early development                                                  Registration
                             development        Phase           Phase                         approval         (LCM)         cialization



              API                             Preclinical     Clinical      GMP Mock
                                                                                                         Variations Renewal
          Manufacturing                        Studies        studies,      Audit GMP                    Transfer Withdrawal
           API Sourcing                                      BE studies      Training                          P&R

                                                                            GMP Mock
                                                                            Audit GMP                     Pharmacovigilance
                                                                             Training

                    RESEARCH & DEVELOPMENT                                       APPROVAL                   COMERCIALIZATION
   5   6   7   8   9   10   11   12   13   14   15